David P. Meeker Salary and Compensation - RHYTHM PHARMACEUTICALS, INC. CEO Pay 2024

In fiscal year 2024, David P. Meeker, Chief Executive Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM), received total compensation of $14.7 million.

David P. Meeker's compensation breakdown includes: base salary of $740K, stock awards valued at $4.4 million, option awards of $8.8 million, non-equity incentive compensation of $744K, and other compensation of $12K.

Compared to fiscal year 2023, David P. Meeker's total compensation increased 103% from $7.2 million to $14.7 million.

RHYTHM PHARMACEUTICALS, INC. (RYTM) Executive Pay 2024

RHYTHM PHARMACEUTICALS, INC.'s top 5 named executive officers received combined total compensation of $33.1 million in fiscal year 2024.

The named executive officers disclosed in RHYTHM PHARMACEUTICALS, INC.'s 2024 proxy statement are:David P. Meeker (Chief Executive Officer) with total compensation of $14.7 million, Yann Mazabraud (Executive Vice President Head of International) with total compensation of $5.6 million, Hunter C. Smith (Chief Financial Officer) with total compensation of $5.1 million, Jennifer Chien (Executive Vice President Head of North America) with total compensation of $4.3 million, and Joseph Shulman (Chief Technical Officer) with total compensation of $3.4 million.